Time to complete oncology pharmacist tasks: A joint opinion of the Hematology/Oncology Pharmacy Association and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research Network
PurposeThe time to complete oncology pharmacist tasks is needed to determine workload and productivity. The Hematology/Oncology Pharmacy Association (HOPA) and the Hematology/Oncology Practice and Research Network (PRN) of the American College of Clinical Pharmacy (ACCP) partnered with the aim of establishing consensus on the time required to complete oncology pharmacy tasks.MethodsFifteen patient care tasks and 9 non-patient care tasks, commonly completed by oncology pharmacists were each assigned an average amount of time to be completed. This list was then converted into 24 statements and the Delphi survey method was utilized with an expert panel to arrive at consensus between December 2023 and February 2024. Consensus was defined as at least 75% agreement. The complete manuscript was endorsed by HOPA and ACCP Hematology/Oncology PRN.ResultsThirty-three pharmacist-experts agreed to participate in this survey with all participating in round 1, and 29 (87.9%) participating in round 2. In round 1, 9 tasks achieved consensus, with 7 of these being classified as patient care associated. Seven statements reaching 65% but less than 75% agreement were deemed to reach borderline consensus. Eight statements failed to achieve at least 65% agreement and were modified based on respondent feedback. In round 2, 15 statements were included with all achieving consensus. At the completion of round 2, all 24 statements reached consensus, and the survey was deemed complete.ConclusionThis project produced the first comprehensive consensus statements for the average time for a US-based oncology pharmacist to complete common patient and non-patient care-related tasks.
Authors
- Rose Cheng
- Grazyna Riebandt
- Nikola Paulic
- Jessie Signorelli (ORCID: https://orcid.org/0000-0003-2881-3452)
- Shawn P. Griffin (ORCID: https://orcid.org/0000-0002-3818-2490)
- Lydia L. Benitez (ORCID: https://orcid.org/0000-0001-6828-8053)
- Vishnuprabha Vogel
- Beejal R. Ganti
- Matthew J Yacobucci (ORCID: https://orcid.org/0000-0002-6388-9623)
- Kristin Adler
- Erin Hickey (ORCID: https://orcid.org/0000-0002-4264-247X)
- Marielle Fares
- Farah Raheem (ORCID: https://orcid.org/0000-0003-1093-5910)
- Alia Lynch
- Aubrey Lasko (ORCID: https://orcid.org/0009-0007-0684-2654)
- David Quach
- Emily Dotson
- Amanda B Lewallen (ORCID: https://orcid.org/0009-0006-1765-9970)
Institutions
- Roswell Park Comprehensive Cancer Center (US)
- Nebraska Medical Center (US)
- Virginia Commonwealth University (US)
- University of California, Irvine (US)
- University of Michigan (US)
- University Hospitals of Cleveland (US)
- University of Virginia Health System (US)
- Center for Open Science (US)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- University of Washington Medical Center (US)
- Albany College of Pharmacy and Health Sciences (US)
- Massachusetts General Hospital (US)
- Fred Hutch Cancer Center (US)
- Michigan Medicine (US)
- Iowa Oncology Research Association (US)
- Ark Therapeutic (United States) (US)
- Mayo Clinic Hospital (US)
- VA Portland Health Care System (US)
Publication Details
- Journal
- Journal of Oncology Pharmacy Practice
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1177/10781552251330252
- Citations
- 2
- Primary Topic
- Innovations in Medical Education
- Type
- article
- Field-Weighted Citation Impact
- 3.76